SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-24-000112
Filing Date
2024-02-06
Accepted
2024-02-06 17:28:39
Documents
1
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 5  
1 ownership.xml 5 5273
  Complete submission text file 0000904454-24-000112.txt   6717
Mailing Address C/O KERYX BIOPHARMACEUTICALS 750 LEXINGTON AVENUE NEW YORK X1 10022
Business Address
Kaye Jack (Reporting) CIK: 0001376099 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36294 | Film No.: 24601348

Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)